AzTrials
AzTrials

Asthma Control LevelNCT00900861

Asthma Control and Clinical Practice in Hungary 2009

An observational study of Asthma Control Level, run by AstraZeneca at 75 sites in Hungary.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A prospective study led amongst pulmonologists. Patients asthma control level will be evaluated based on GINA guideline criteria. HRQoL measured by Visual analogue scale. Clinical practice: non controlled patients therapy assessed. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Asthma Control Level
How many people
3,000 participants
Where
75 sitesHungary
Study dates
Apr 2009to Nov 2009
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Pulmonology outpatient clinics

Who may be able to join

  • Asthma patients treated with ICS or bronchodilators

Who cannot join

  • COPD
  • pulmonary cancer
  • pulmonary tuberculosis

Trial locations and contacts

75 sites in 1 country.

75 sites in 1 country

Hungary75 sites
  • Research Site

    Aszód

  • Research Site

    Bácsalmás

  • Research Site

    Baja

  • Research Site

    Baktalórántháza

  • Research Site

    Balassagyarmat

  • Research Site

    Békés

  • Research Site

    Békéscsaba

  • Research Site

    Berettyóújfalu

  • Research Site

    Bonyhád

  • Research Site

    Cegléd

  • Research Site

    Celldömölk

  • Research Site

    Csorna

  • Research Site

    Dabas

  • Research Site

    Debrecen

  • Research Site

    Dombóvár

  • Research Site

    Dunaharaszti

  • Research Site

    Dunaújváros

  • Research Site

    Dunavecse

  • Research Site

    Edelény

  • Research Site

    Eger

  • Research Site

    Encs

  • Research Site

    Érd

  • Research Site

    Esztergom

  • Research Site

    Gávavencsellő

  • Research Site

    Gödöllő

  • Research Site

    Győr

  • Research Site

    Győrújbarát

  • Research Site

    Gyungyos

  • Research Site

    Hajdúnánás

  • Research Site

    Hatvan

  • Research Site

    Ikrény

  • Research Site

    Jászberény

  • Research Site

    Kaposvár

  • Research Site

    Kapuvár

  • Research Site

    Kazincbarcika

  • Research Site

    Keszthely

  • Research Site

    Kisbér

  • Research Site

    Kiskőrös

  • Research Site

    Kiskunhalas

  • Research Site

    Kistelek

  • Research Site

    Kisvárda

  • Research Site

    Mátészalka

  • Research Site

    Mezőkövesd

  • Research Site

    Miskolc

  • Research Site

    Monor

  • Research Site

    Mór

  • Research Site

    Mosonmagyaróvár

  • Research Site

    Nagyatád

  • Research Site

    Nagykőrös

  • Research Site

    Nyírbátor

  • Research Site

    Nyíregyháza

  • Research Site

    Orosháza

  • Research Site

    Ózd

  • Research Site

    Pápa

  • Research Site

    Pásztó

  • Research Site

    Pécs

  • Research Site

    Salgótarján

  • Research Site

    Sárbogárd

  • Research Site

    Sárvár

  • Research Site

    Siófok

  • Research Site

    Szarvas

  • Research Site

    Százhalombatta

  • Research Site

    Szécsény

  • Research Site

    Szeged

  • Research Site

    Székesfehérvár

  • Research Site

    Szentendre

  • Research Site

    Szerencs

  • Research Site

    Szolnok

  • Research Site

    Tapolca

  • Research Site

    Tata

  • Research Site

    Tiszalök

  • Research Site

    Tiszaújváros

  • Research Site

    Törökbálint

  • Research Site

    Vác

  • Research Site

    Vásárosnamény

Other trials in Hungary

About this study

A prospective study led amongst pulmonologists. Patients asthma control level will be evaluated based on GINA guideline criteria. HRQoL measured by Visual analogue scale. Clinical practice: non controlled patients therapy assessed.

Keywords
asthma control level, visual analogue scale

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00900861
Study groupRoleWhat they receive
1Asthmatic patients above 18 y, treated with ICS or bronchodilators

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Asthma control level

    Measured: 3 times

Secondary outcomes (2)
  1. Visual Analogue Scale

    Measured: 3 times

  2. Routine Therapeutical habits in control maintenance

    Measured: 3 times

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2009 (estimated)
  2. Study startApr 2009
  3. Study completionNov 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
3,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00900861
Sponsor's protocol ID
NIS-RHU-DUM-2009/1
Status last verified
Dec 2009
First submitted
12 May 2009
Last updated
4 Dec 2009
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Asthma Control Level, run by AstraZeneca at 75 sites in Hungary.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Dec 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 75 sites in Hungary. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Asthma control level (time frame: 3 times). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in